4-gene panel for familial hypercholesterolemia (LDLR, APOB, PCSK9, LDLRAP1).
A focused 4-gene panel for familial hypercholesterolemia, covering LDLR, APOB, PCSK9, and LDLRAP1.
This is a predictive genetic test.
The order page will ask you to either book counseling or waive counseling in writing per German GenDG §10. Your choice is fully documented and accessible at any time.
Order in three clicks, no login. Kit ships from Berlin within 5 working days.
Follow the guided sample collection. Your AI-interpreted clinical report arrives by secure email.
Discuss findings with your physician or our medical geneticist; retest as your interventions evolve.
Do you carry inherited variants that cause your body to handle cholesterol abnormally from birth, leading to early heart disease?
Atlas analyzes each gene in its entirety -- not just hotspot regions -- against current clinical literature. Findings are reviewed by a board-certified medical geneticist before release.
A focused 4-gene panel for familial hypercholesterolemia (FH) -- the inherited form of high LDL cholesterol that affects roughly 1 in 250 people and is heavily underdiagnosed. Variants in LDLR, APOB, PCSK9, or LDLRAP1 disrupt the LDL receptor pathway, leaving LDL chronically elevated from birth.
Gene list per CeGaT PRV05 (2026-05).
Untreated FH carries roughly a 20-fold lifetime risk of premature coronary heart disease. Identifying it allows a physician to begin statin therapy early -- often in adolescence or young adulthood -- which substantially normalizes lifetime cardiovascular risk. Lipid panels alone often miss FH because cholesterol elevation is interpreted as lifestyle-driven.
Every Atlas predictive report uses the same five-outcome framework so you and your physician can read it the same way each time.
Increased disease risk. The report includes an individualized prevention plan and a recommendation to discuss next steps with a physician or medical geneticist.
Probable disease association. Preventive monitoring is typically justified; the strength of evidence is documented in the report.
Reported but not currently actionable. A VUS may be reclassified over time as new evidence accumulates -- Atlas does not act on VUS findings without specialist review.
No pathogenic or likely-pathogenic variant was identified in the analyzed genes. This does not eliminate all genetic risk -- only the genes in this panel were assessed.
When an actionable variant is found, cascade testing of first-degree relatives is typically recommended -- a decision made together with a counselor.
Predictive genetic testing in Germany requires consultation with a physician qualified in human genetics under §7 of the GenDG (Arztvorbehalt). Atlas Counseling provides this before and after the test. When an actionable finding has implications for relatives, your counselor will discuss cascade testing -- not Atlas alone.
A variant indicates predisposition. It does not confirm a condition is currently present.
Imaging, lab work, and physical examination remain part of clinical care. Atlas results inform them; they do not substitute for them.
Environment, behavior, age, and chance contribute to most common conditions. A genetic test reads one input.
Only the genes on the panel were analyzed. Variants in other genes, in non-coding regions, and outside the assay's technical scope are not assessed.
Atlas reports are designed to be reviewed with a physician or medical geneticist. We do not recommend acting on a finding without that conversation.
GenDG §7
Predictive panels on this page are GenDG §7 Arztvorbehalt: counseling with a qualified human-genetics physician is required before and after the test. Atlas Counseling is included in the order flow.
Ready to start? €290 · 3–4 weeks after sample arrival
Order →Not sure if this is the right protocol? Let Atlas walk you through a few questions. Start Triage →
Or browse all 24 protocols: Open the Console →
Not ready? Book a counseling session first →
Already have your genome with Atlas?
See Atlas Baseline